An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib

Ravi Vij, David S. Siegel, Sundar Jagannath, Andrzej J. Jakubowiak, Alexander Keith Stewart, Kevin Mcdonagh, Nizar Bahlis, Andrew Belch, Lori A. Kunkel, Sandra Wear, Alvin F. Wong, Robert Z. Orlowski, Michael Wang

Research output: Contribution to journal › Article › peer-review

153 Scopus citations

Fingerprint

Dive into the research topics of 'An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib'. Together they form a unique fingerprint.

Medicine & Life Sciences